Dr. David L. Nathin, MD

Dr. Nathin practices at Riverview Medical Center in Red Bank, New Jersey, part of Hackensack Meridian Health.

Dr. Nathin's NPI, 1457883159, was assigned on March 31, 2017. Dr. Nathin holds New Jersey license 25MA10866700.

Dr. Nathin's primary practice is Riverview Medical Center, at One Riverview Plaza, Red Bank, NJ 07701 in Monmouth County. The practice phone is (732) 741-2700. Dr. Nathin also practices at Riverview Medical Center, 1 Riverview Plz, Red Bank, NJ 07701.

Dr. Nathin's primary practice is Riverview Medical Center in Red Bank, New Jersey, part of Hackensack Meridian Health. Dr. Nathin is also affiliated with Memorial Sloan Kettering Cancer Center. The medical group on file is Memorial Sloan Kettering Monmouth. Dmand AI also links Dr. Nathin to 1 more hospital, 1 group practice or clinic, 1 hospice and 1 medical group, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Nathin practices, 5 sites in all. Vendor and product names are available with a free account.

Hospitalist is Dr. Nathin's primary specialty in the NPI Registry, under taxonomy code 208M00000X. Dr. Nathin is licensed in New Jersey.

CMS data shows 1,825 Medicare services from Dr. Nathin across 6 procedure codes in 2024, for 635 Medicare patients. Medicare paid $154,747 for them. Every service was in a facility, such as a hospital, rather than an office.

CMS counts 635 Medicare patients who saw Dr. Nathin in 2024. The largest group is 75 to 84, with 238 patients. 75% of them have high blood pressure, and 75% have high cholesterol. 9% are also on Medicaid. Their average risk score is 2.18, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Dr. Nathin's median patient age at 72, with 54% women.

In 2024, Dr. Nathin wrote 433 Medicare Part D claims for 142 patients. 90% of them were for generic drugs. CMS names the drug for 110 of them, across 8 drugs with 11 or more claims each, at $2,314 in total drug cost. In 2023, CMS named 66 claims across 4 drugs.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 85 out of 100 for Dr. Nathin for performance year 2024, reported individually. Dr. Nathin accepts Medicare assignment, so Medicare's approved amount is taken as full payment.

CMS Open Payments shows 13 general payments to Dr. Nathin from 5 drug and device companies from 2021 to 2025. Food and beverage make up the largest share, 100% of the total. Pfizer Inc. paid the most, $96.